Christina R. Valauri Joins Health In Tech Board, Bringing Expert Governance and Leadership
Health In Tech, Inc., a notable player in the AI-driven InsurTech landscape, has recently appointed Christina R. Valauri as an independent director on its Board, effective November 12, 2026. Christina brings with her a wealth of experience from over 30 years in the financial services sector, which includes prominent roles at major firms such as Cantor Fitzgerald and Natixis. Her diverse expertise spans capital markets, corporate governance, and strategic advisory, giving Health In Tech valuable insights as they continue to innovate within the health insurance space.
As a strategic member of several committees, including the Audit Committee and the Compensation Committee, Christina will greatly contribute to the governance and operational oversight of the company. Previously, she held senior positions that required both analytical acumen and leadership, driving substantial transformation in the organizations she has served. Christina was notably the Global Director of Equity Research at Cantor Fitzgerald and co-head of Equity Capital Markets at First Albany, positions which reflect her high standing in the capital markets arena.
Sanjay Shrestha, CEO of Health In Tech, expressed enthusiasm about Christina’s appointment, emphasizing her unique blend of Wall Street leadership and thorough understanding of the healthcare industry. "Christina can discern how institutional investors evaluate various aspects of a company, from its management to its competitive edge and growth potential. This is invaluable as we aim to enhance our AI-enabled marketplace and boost our distribution channels. Her experience with emerging healthcare businesses will also offer a practical viewpoint regarding the commercialization process and the necessary capabilities for scaling effectively," he stated.
Throughout her career, Valauri has been recognized for her analytical expertise in healthcare investment research, achieving recognition as the top analyst in the biomedical and biotechnology sectors according to The Wall Street Journal's All-Star Analyst Survey. This accolade underlines her authority and influence within the financial fabrics of healthcare technology—a field that is constantly evolving and ripe with opportunities.
In addition to her role at Health In Tech, Valauri serves as an independent director on the boards of other Nasdaq-listed companies, further showcasing her proficiency in corporate governance. Her leadership extends to her position as the Founder and CEO of Sagestone Advisory LLC, through which she provides business strategy and capital market guidance to burgeoning organizations. Moreover, Christina plays a significant role as a Mentor and Guest Lecturer at Weill Cornell Medicine's BioVenture eLab, where she supports the commercialization of cutting-edge healthcare technologies, thus bridging her extensive experience with the next generation of innovators in the field.
Christina holds an Executive MBA from Cornell University and a Bachelor of Arts in Biology from Reed College. Her academic background, coupled with her professional qualifications, including her certification as a National Association of Corporate Directors (NACD) certified director, positions her uniquely to guide Health In Tech through its next chapter of growth.
This strategic addition to the board aligns with Health In Tech's mission to improve processes in the health insurance industry, particularly through innovations that simplify and automate procedures for insurance providers. As the firm continues to enhance its marketplace offerings, including self-funded health insurance solutions, Christina's insights will be pivotal in ensuring that the company not only meets industry standards but also sets new benchmarks for excellence.
With her extensive experience and demonstrated leadership, Christina R. Valauri embodies the vision Health In Tech has for sustainable growth and stakeholder value. The company looks forward to leveraging her insights and skills as it charts its course in the rapidly advancing InsurTech domain.